Drug development and adverse reactions

All Items

• Inhibition of Transforming Growth Factor Beta and Immune Checkpoints Induces a Distinctively Distributed, Severe Bullous Pemphigoid

  Soo Hyun Choi, Kyung Bae Chung, Do-Young Kim

  adv00489

• Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa

  Patricia Garbayo-Salmons, Mireia Moreno Martínez-Losa, Vicente Exposito-Serrano, Miquel Ribera, Joan

  adv40145

• Langerhans Cell Histiocytosis Caused by Adalimumab for Crohn’s Disease: A Case Report

  Mariko Kochi, Tetsuya Higuchi

  adv10285

• Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited

  Elisa Ríos-Viñuela, Eduardo Bernia, Tomás Toledo-Pastrana, Celia Requena, Adrián Diago, Carlos Serra-Guillén, Beatriz Llombart, Victor Traves, Eduardo Nagore, Carlos Guillén, Onofre Sanmartin

  adv00429

• Löfgren’s Syndrome Following BNT162b2 mRNA COVID-19 Vaccination and Subsequent Plaque-type Cutaneous Sarcoidosis after its Resolution

  Masahiro Oka, Takeshi Fukumoto

  adv42566

• Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience

  Tiffany J. Garcia-Saleem, Connor J. Stonesifer, Alexandra E. Khaleel, Larisa J. Geskin

  adv00544

• Melanoma during Ruxolitinib Treatment for Myelofibrosis

  Lingzhi Zhong, Houmin Li, Guangdong Wen

  adv44196

• Minocycline-induced Hyperpigmentation Confined to Lupus Miliaris Disseminatus Faciei

  Masakazu Kakurai, Rie Honda, Hanako Miyahara, Shusaku Ito

  adv18462

• Mucocutaneous Adverse Reactions to COVID-19 Vaccines: Do Excipients Play a Role?

  Leonardo Bianchi, Filippo Biondi, Katharina Hansel, Nicola Murgia, Alessandro D'Arpino, Marta Tramontana, Luca Stingeni

  adv00724

• Mucosal Fixed Drug Eruption with Oral, Conjunctival, Nasal, and Anal Lesions: A Case Report

  Noriko Yoshida, Fumi Miyagawa, Yasuhiro Mitsui, Kohei Ogawa, Takashi Hashimoto, Hideo Asada

  adv18295

• Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects

  Jana D. Albrecht, Nadia Ninosu, Denise Barry, Thomas Albrecht, Marthe-Lisa Schaarschmidt, Sergij Goerdt, Jan P. Nicolay

  adv00722

• Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab

  Dimitrii Pogorelov, Heribert Strotkötter, Vesna Bjelic-Radisic, Ulrich Wesselmann, Jonas Hübinger, Simona Sabulyte, Silke C. Hofmann, Galina Balakirski

  adv40801

• Painful Erythematous Plaques on the Hands: A Quiz

  Anna Ochi, Yasuhiro Mitsui, Kohei Ogawa, Hideo Asada

  adv12344

• Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors

  Aurore Devoldere, Clélia Vanhaecke, Pauline Soibinet, Brahim Azzouz, Manuelle Viguier

  adv42291

• Pemphigoid with Autoantibodies against p200 and all Subunits of Laminin 332 Associated with Drug Eruption Caused by Piperacillin/tazobactam

  Hanako Miyahara, Rie Honda, Shusaku Ito, Norito Ishii, Toshifumi Nomura

  adv41369

• Pityriasis Lichenoides et Varioliformis Acuta Triggered by Human Papillomavirus Vaccine: A Case Report and Literature Review

  Beata A. Jastrząb, Aleksandra A. Stefaniak, Anita Hryncewicz-Gwóźdź, Piotr Nockowski, Jacek C. Szepietowski

  adv00552

• Possible Clinical Effects of Ketoconazole on Sorafenib-induced Hand–Foot Skin Reaction and Cytoprotection Mechanisms of Antifungal Agents against Multikinase Inhibitor-induced Keratinocyte Toxicity

  Rui Kato, Yayoi Kamata, Mitsutoshi Tominaga, Ryoma Kishi, Takahide Kaneko, Akira Tsujimura, Yasushi Suga, Kenji Takamori

  adv40697

• Primary Cutaneous B-cell Lymphoma Leg-type Related to a Tumour Necrosis Factor Alpha Inhibitor

  Samy Belkaïd, Brigitte Balme, Olivier Harou, Joann Le Borgne de la Villandré, Chloé Wirbel, Stéphane Dalle, Florent Grange

  adv00688

• Prognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris

  Tal Raviv, Keren Pevzner, Aviv Barzilai, Felix Pavlotsky, Sharon Baum

  adv27140

• Propylthiouracil-induced Alopecia Accompanying Hypohidrosis and Onychomadesis

  Nozomi Yanagida, Shunsuke Takahagi, Akio Tanaka, Michihiro Hide

  adv00763

• Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?

  David Pesqué, Blanca Sanchez-Gonzalez, Fernando Gallardo, Sonia Segura, Ramon M. Pujol

  adv00418

• Psoriatic Skin Lesions after Apalutamide Treatment

  Fumi Miyagawa, Nobuya Akioka, Noriko Yoshida, Kohei Ogawa, Hideo Asada

  adv00659

• Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab

  Mingxia Wang, Qi Zheng, Suwei Tang, Fang Shen, Wenchen Jiang

  adv00744

• Real-world Experience of Abrocitinib on Difficult-to-treat Hand Eczema in Chinese Patients

  Yiting Li, Xi Tan, Shu Nie, Xin Tian, Zhouwei Wu

  adv39822

• Real–world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review

  Shihua Ling, Xia Dou

  adv43588

• Recurrent Vesiculonecrotic Lesions on the Lower Extremities in a Patient with Dermatomyositis: A Quiz

  Zhen-Dong Wei, Yi-Ping Zhao, Chao Yu, Xin-Yue Ding, Ao-Xue Wang

  adv42967

• Repeated Annular Erythema on the Trunk: A Quiz

  Yoshihito Mima, Tsutomu Ohtsuka, Ippei Ebato, Yoshimasa Nakazato, Yuta Norimatsu

  adv40867

• Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review

  Diva Amiri, Christopher Willy Schwarz, Lise Gether, Lone Skov

  adv00890

• Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis

  Verónica Sánchez-García, Eva de-Miguel-Balsa, José-Manuel Ramos-Rincón, Isabel Belinchón-Romero

  adv41307

• Safety, Pharmacokinetics, and Efficiency of JS005, a Novel Anti-interleukin-17A Monoclonal Antibody, in Healthy Chinese Adults and Patients with Moderate to Severe Psoriasis

  Lin Cai, Huichen Liu, Zhanglei Mu, Xiaohua Tao, Litao Zhang, Chunlei Zhang, Yumei Li, Guoqiang Zhang, Furen Zhang, Xiuqin Dong, Chengxin Li, Aijun Chen, Zhuning Wu, Yuxian Zhu, Mengqi Zhang, Jiangnian Liu, Aiming Li, Jianzhong Zhang

  adv41105

• Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases

  Sonja Braasch, Carsten Weishaupt, Eva Spukti, Markus Böhm, Stephan Alexander Braun

  adv00792

• Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study

  Lina Renkhold, Manuel P. Pereira, Karin Loser, Dieter Metze, Daniel Baeumer, Nima Melzer, Maximilian Reinhardt, Athanasios Tsianakas, Thomas Luger, Christian Mess, Ruth Becker, Clara Hambüchen, Konstantin Agelopoulos, Sonja Ständer

  adv40737

• Severe Acute Generalized Exanthematous Pustulosis Successfully Treated by Spesolimab

  Giuseppe Russo, Shireen Dumont, Sébastien Menzinger, Damien Pastor, Laurence Toutous Trellu, Gürkan Kaya, Emmanuel Laffitte

  adv41311

• Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma

  Quentin Samaran, Marilou Duboëlle, Anaïs Marque, Virginie Bres, Olivier Dereure

  adv-2025-0279

• Simultaneous Development of Gianotti-Crosti Syndrome and Erythema Multiforme Following Second Dose of Measles-rubella Vaccine

  Masahiro Oka

  adv00438

• Skin Rash on Immunotherapy: When Trombicula Mimics a Cutaneous Immune-related Adverse Event

  Léa Frigout, Taha Tagmouti, Pierre Goineau, Anne Dompmartin, Jean Matthieu L’Orphelin

  adv43467

• Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients

  Ji Su Lee, Jimin Woo, Tae Min Kim, Namkyu Kim, Bhumsuk Keam, Seong Jin Jo

  adv40555

• Spontaneous Mucocutaneous Ulcerations: A Quiz

  Jakob L. Drivenes, Anette Bygum

  adv41006

• Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

  Tanja Batinac, Nika Hlača, Luka Simetić, Frane Valković, Sandra Peternel, Larisa Prpić-Massari

  adv00650

• Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata

  S. Morteza Seyed Jafari, Pierre A. de Viragh

  adv44193

• Successful Control of Refractory Hidradenitis Suppurativa with Spesolimab: A Case Report

  Yangfan Lai, Yanzhuo Hu, Xiaoyao Fan, Baishuang Yue, Ying Ma

  adv43329

• Successful Treatment of Comorbid SAPHO Syndrome and Hidradenitis Suppurativa with Upadacitinib

  Deepika Narayanan, Tiffaney Tran, Valeria Duque-Clavijo, Hung Q. Doan, Stephen K. Tyring

  adv44265

• Successful Treatment of Paediatric Morphea with Tofacitinib

  Jun-Chi Tang, Wen-Yue Zheng; Guang-Ming Han, Shuang-fei Liu; Bin Yang

  adv4805

• Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-up

  Javier Gil-Lianes, Mar Luque-Luna, Francesc Alamon-Reig, Xavier Bosch-Amate, Laura Serra-Garcia, José M. Mascaró Jr.

  adv18284

• Telangiectasia Macularis Multiplex Acquisita and its Potential Association with Calcium Channel Blockers: A Retrospective Study of 46 Chinese Patients

  Tian Chen, Jia-Wei Liu, Yue-Tong Qian, Xing-Yu Li, Xiao Ma, Jing-Wen Wang, Dong-Lai Ma

  adv40447

• Terbinafine Resistant Trichophyton Indotineae in Sweden

  Sahel Mohseni, Nissrine Abou-Chakra, Karl Oldberg, Erja Chryssanthou, Ewa Young

  adv42089

• Teriflunomide-induced Palmoplantar Lichenoid Eruption: A Case Report

  Gökçe Işıl Kurmuş, Şükran Cansu Tiryaki Buyruk, Dilek Menteşoğlu, Selda Pelin Kartal, Murat Alper

  adv40967

• The Absence of Recent Systemic Therapy can be a Significant Risk Factor for Nemolizumab-associated Cutaneous Adverse Events in Patients with Prurigo Nodularis: A Single-centre Retrospective Study

  Yoshihito Mima, Masako Yamamoto, Ken Iozumi

  adv44310

• Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications

  Anna M. Halupczok, Ann-Sophie Bohne, Sascha Gerdes, Stephan Weidinger, Michael Weichenthal

  adv35215

• Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy

  Kana Osawa, Yukiko Kiniwa, Yuzuki Shimosato, Hirotaka Midorikawa, Takushi Shirai, Tasuku Sano, Kenta Nakamura, Ryuhei Okuyama

  adv00723